I. Friedrich - Concepedia

Author

I. Friedrich

University of Freiburg

Also Known As

A. Rißmann, Friedrich, Isolde, I A Friedrich, I Friedrich, I. Friedrich, Isolde Friedrich

Publications

785

Citations

H-Index

Concepts

All Affiliations

University of Freiburg University of Graz University Medical Center Freiburg

About

I. Friedrich is an author at University of Freiburg specializing in medicine, atherosclerosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	374
2	Public Health	4	4	324
3	Biochemistry	3	3	159
4	Health Sciences	2	2	52
5	Natural Sciences	1	1	34

I. Friedrich

Publications

727

Citations

H-Index

Page 1

	Year	Citations
Triglyceride-Rich Lipoproteins Are Associated with Hypertension in Preeclampsia Karl Winkler, B. Wetzka, Michael M. Hoffmann, The Journal of Clinical Endocrinology & Metabolism HypertensionPregnancy DisordersGynecologyHyperlipidemiaTriglyceride-rich Lipoproteins	2003	121
Pioglitazone Reduces Atherogenic Dense LDL Particles in Nondiabetic Patients With Arterial Hypertension Karl Winkler, Thomas R. Konrad, S. Füllert, Diabetes Care	2003	104
Low Density Lipoprotein (LDL) Subfractions during Pregnancy: Accumulation of Buoyant LDL with Advancing Gestation Karl Winkler, B. Wetzka, Michael M. Hoffmann, The Journal of Clinical Endocrinology & Metabolism GynecologyFetal HealthHyperlipidemiaBuoyant LdlLow Density	2000	100
Fluvastatin Slow-Release Lowers Platelet-Activating Factor Acetyl Hydrolase Activity: A Placebo-Controlled Trial in Patients with Type 2 Diabetes Karl Winkler, C. Abletshauser, I. Friedrich, The Journal of Clinical Endocrinology & Metabolism Fluvastatin TreatmentPlacebo-controlled TrialHyperlipidemiaMetabolic SyndromeThrombosis	2004	78
Competition of Aβ amyloid peptide and apolipoprotein E for receptor-mediated endocytosis Karl Winkler, Hubert Scharnagl, U Tisljar, Journal of Lipid Research	1999	65
Lipoprotein-Associated Phospholipase A2 Predicts 5-Year Cardiac Mortality Independently of Established Risk Factors and Adds Prognostic Information in Patients with Low and Medium High-Sensitivity C-Reactive Protein (The Ludwigshafen Risk and Cardiovascular Health Study) Karl Winkler, Michael M. Hoffmann, Bernhard R. Winkelmann, Clinical Chemistry	2007	60
Effect of Fluvastatin Slow-Release on Low Density Lipoprotein (LDL) Subfractions in Patients with Type 2 Diabetes Mellitus: Baseline LDL Profile Determines Specific Mode of Action Karl Winkler, C. Abletshauser, Michael M. Hoffmann, The Journal of Clinical Endocrinology & Metabolism	2002	55
Clearance of postprandial lipoproteins in normolipemics: role of the apolipoprotein E phenotype Matthias Orth, Sabine Wahl, M Hanisch, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism Metabolic SyndromeLipid DisorderBiochemistryCardiovascular DiseaseApolipoprotein E Phenotype	1996	34
The association of remote Streptococcus bovis bacteremia with colonic neoplasia. I. Friedrich, Gary P. Wormser, Edward B. Gottfried PubMed Medical MicrobiologyMicrobial DiseaseColonic NeoplasiaRemote HistoryGastroenterology	1982	32
Qualitative Effect of Fenofibrate and Quantitative Effect of Atorvastatin on LDL Profile in Combined Hyperlipidemia with dense LDL K. Winkler, P. Weltzien, I. Friedrich, Experimental and Clinical Endocrinology & Diabetes	2004	25

Page 1